The Conundrum of Lung Disease and Drug Hypersensitivity‐like Reactions in Systemic Juvenile Idiopathic Arthritis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Conundrum of Lung Disease and Drug Hypersensitivity‐like Reactions in Systemic Juvenile Idiopathic Arthritis
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-04-13
DOI
10.1002/art.42137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anakinra in patients with systemic juvenile idiopathic arthritis: long-term safety from the Pharmachild registry
- (2022) Gabriella Giancane et al. JOURNAL OF RHEUMATOLOGY
- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
- (2022) Kjetil Bjornevik et al. SCIENCE
- A dysregulated interleukin-18–interferon-γ–CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis
- (2021) Tanja Hinze et al. RHEUMATOLOGY
- Clinical, biochemical and serological predictors of DRESS syndrome: a prospective case-control study
- (2021) Rajat Choudhary et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- THE IL-18/IFNγ AXIS IN SYSTEMIC JIA AND MAS – NEW ANSWERS, MORE QUESTIONS
- (2021) Grant S Schulert RHEUMATOLOGY
- Genetics of Severe Cutaneous Adverse Reactions
- (2021) Shang-Chen Yang et al. Frontiers in Medicine
- Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
- (2021) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity
- (2021) Alexandra Schnell et al. CELL
- Efficacy and Safety of Canakinumab in sJIA Patients with and without Fever at Baseline: Results from an Open‐label, Active Treatment Extension Study
- (2020) Hermine I Brunner et al. Arthritis & Rheumatology
- TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity
- (2020) Stacey N. Harbour et al. Science Immunology
- HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
- (2020) Jian Wang et al. CELL
- Cytokine regulated Th17 plasticity in human health and diseases
- (2020) Silvia Cerboni et al. IMMUNOLOGY
- Early treatment and il1rn snps affect response to anakinra in systemic juvenile idiopathic arthritis
- (2020) Manuela Pardeo et al. Arthritis & Rheumatology
- Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study
- (2019) Nienke M. ter Haar et al. Arthritis & Rheumatology
- Emergent high fatality lung disease in systemic juvenile arthritis
- (2019) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Biological and clinical significance of Th17 cell plasticity
- (2019) Alessio Mazzoni et al. IMMUNOLOGY
- Pulmonary Manifestations of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Systematic Review
- (2019) Pahnwat Tonya Taweesedt et al. Biomed Research International
- Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis
- (2019) Peter A. Nigrovic Arthritis & Rheumatology
- Allergic bronchopulmonary aspergillosis
- (2019) Gayatri Patel et al. ALLERGY AND ASTHMA PROCEEDINGS
- Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity
- (2019) Paula Araya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tocilizumab-induced anaphylaxis in patients with adult-onset Still’s disease and systemic juvenile idiopathic arthritis: a case-based review
- (2019) Eun Hye Park et al. RHEUMATOLOGY INTERNATIONAL
- Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors
- (2019) Grant S. Schulert et al. Arthritis & Rheumatology
- A cellular and molecular view of T helper 17 cell plasticity in autoimmunity
- (2018) Ralph Stadhouders et al. JOURNAL OF AUTOIMMUNITY
- The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation
- (2018) Takayoshi Komatsu-Fujii et al. ALLERGOLOGY INTERNATIONAL
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
- (2017) Kelly D. Sullivan et al. Scientific Reports
- Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis
- (2017) Christoph Kessel et al. Arthritis & Rheumatology
- Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells
- (2017) Samantha Reiss et al. PLoS One
- Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- (2016) Claudia Bracaglia et al. ANNALS OF THE RHEUMATIC DISEASES
- Trisomy 21 consistently activates the interferon response
- (2016) Kelly D Sullivan et al. eLife
- Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity
- (2015) Jellert T. Gaublomme et al. CELL
- Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response
- (2015) Katie D. White et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation
- (2015) Nicola Gagliani et al. NATURE
- Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis
- (2015) Peter A. Nigrovic PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HLA-DRB1*11and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
- (2015) Michael J. Ombrello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of CD8+ T lymphocyte repertoire spreading with the severity of DRESS syndrome
- (2015) Jun Niu et al. Scientific Reports
- Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell–attracting chemokine, and interleukin-10
- (2014) Fang Wang et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung
- (2014) S. Iriguchi et al. BLOOD
- Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)
- (2014) K. Ogawa et al. BRITISH JOURNAL OF DERMATOLOGY
- Genetic predictors of Stevens–Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population
- (2014) Wei Wang et al. EPILEPSY & BEHAVIOR
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
- (2013) S.H. Kardaun et al. BRITISH JOURNAL OF DERMATOLOGY
- Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)
- (2012) Kohei Ogawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis
- (2012) E. Omoyinmi et al. RHEUMATOLOGY
- Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
- (2012) Yukiko Kimura et al. ARTHRITIS CARE & RESEARCH
- Rapid In Vivo Conversion of Effector T Cells into Th2 Cells during Helminth Infection
- (2011) M. Panzer et al. JOURNAL OF IMMUNOLOGY
- Fate mapping of IL-17-producing T cells in inflammatory responses
- (2011) Keiji Hirota et al. NATURE IMMUNOLOGY
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Primary pulmonary hypertension in a patient with systemic-onset juvenile arthritis
- (2010) Shai Padeh et al. ARTHRITIS AND RHEUMATISM
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
- IL-1β and IL-2 convert human Treg into TH17 cells
- (2009) Florence Deknuydt et al. CLINICAL IMMUNOLOGY
- Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
- (2008) H. J. P. M. Koenen et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started